Tacrolimus Analogue Set
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-05742 | ||
Tacrolimus EP Impurity C is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. |
||
BBF-05743 | ||
19-epi Tacrolimus is an impurity of Tacrolimus. Tacrolimus is an immunosuppressant that can inhibit the activity of FK-506 binding protein. |
||
BBF-05744 |
Tacrolimus EP Impurity H (143210-33-7) Inquiry |
|
Tacrolimus EP Impurity H is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. |
||
BBF-05768 |
Tacrolimus (104987-11-3) Inquiry |
|
FK-506 is a 23-membered macrolide lactone, it reduces peptidyl-prolyl isomerase activity by binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex. |
||
BBF-05770 |
Tacrolimus EP Impurity I (104987-16-8) Inquiry |
|
Tacrolimus EP Impurity I is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. |
||
BBF-05771 |
Tacrolimus EP Impurity D (129212-35-7) Inquiry |
|
Tacrolimus EP Impurity D is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. |
||
BBF-05775 |
Tacrolimus Impurity (Methyl Acryl Aldehyde) (109466-74-2) Inquiry |
|
Tacrolimus Impurity (Methyl Acryl Aldehyde) is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. |
||
BBF-05773 |
Tacrolimus EP Impurity E (104987-30-6) Inquiry |
|
Tacrolimus EP Impurity E is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. |
||
BBF-05769 |
Oxacyclohexane open ring tacrolimus (144432-23-5) Inquiry |
|
Oxacyclohexane open ring tacrolimus is an impurity of Tacrolimus, which is a macrolide drug that is widely used as a potent immunosuppressant. |
||
BBF-05774 |
Tacrolimus EP Impurity A (104987-12-4) Inquiry |
|
Ascomycin, isolated from Streptomyces, suppresses immune response in vitro with IC50 of 0.55 nM for mouse mixed lymphocyte. |
||
BBF-05772 |
Tacrolimus EP Impurity G (144490-63-1) Inquiry |
|
Tacrolimus EP Impurity G is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. |